Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $62.21 million. The enterprise value is $63.17 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 59.24 million shares outstanding. The number of shares has increased by 8.12% in one year.
| Current Share Class | 59.24M |
| Shares Outstanding | 59.24M |
| Shares Change (YoY) | +8.12% |
| Shares Change (QoQ) | +3.94% |
| Owned by Insiders (%) | 37.01% |
| Owned by Institutions (%) | 10.24% |
| Float | 31.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 1.10.
| Current Ratio | 3.41 |
| Quick Ratio | 3.11 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -122.42% and return on invested capital (ROIC) is -39.35%.
| Return on Equity (ROE) | -122.42% |
| Return on Assets (ROA) | -35.31% |
| Return on Invested Capital (ROIC) | -39.35% |
| Return on Capital Employed (ROCE) | -69.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$634,757 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.31% in the last 52 weeks. The beta is 3.32, so Vivani Medical's price volatility has been higher than the market average.
| Beta (5Y) | 3.32 |
| 52-Week Price Change | -39.31% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 50.23 |
| Average Volume (20 Days) | 101,345 |
Short Selling Information
The latest short interest is 374,492, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 374,492 |
| Short Previous Month | 283,332 |
| Short % of Shares Out | 0.63% |
| Short % of Float | 1.21% |
| Short Ratio (days to cover) | 3.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.68M |
| Pretax Income | -25.37M |
| Net Income | -23.49M |
| EBITDA | -24.28M |
| EBIT | -24.68M |
| Earnings Per Share (EPS) | -$0.43 |
Full Income StatementBalance Sheet
The company has $18.35 million in cash and $19.31 million in debt, giving a net cash position of -$961,000 or -$0.02 per share.
| Cash & Cash Equivalents | 18.35M |
| Total Debt | 19.31M |
| Net Cash | -961,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 17.61M |
| Book Value Per Share | 0.30 |
| Working Capital | 14.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.79 million and capital expenditures -$556,000, giving a free cash flow of -$21.34 million.
| Operating Cash Flow | -20.79M |
| Capital Expenditures | -556,000 |
| Free Cash Flow | -21.34M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |